| XIST |
|
X inactive specific transcript
|
|
|
0.522 |
0.808 |
| IGHV1-12 |
|
immunoglobulin heavy variable 1-12 (pseudogene)
|
|
|
0.569 |
0.654 |
| MIR367 |
|
microRNA 367
|
|
|
0.590 |
0.654 |
| POU5F1P3 |
|
POU class 5 homeobox 1 pseudogene 3
|
|
|
0.452 |
0.808 |
| POU5F1P4 |
|
POU class 5 homeobox 1 pseudogene 4
|
|
|
0.452 |
0.808 |
| PSMD10 |
O75832
|
proteasome 26S subunit, non-ATPase 10
|
|
0.50 |
0.552 |
0.808 |
| BCL10 |
O95999
|
BCL10 immune signaling adaptor
|
|
0.34 |
0.491 |
0.769 |
| KRAS |
P01116
|
KRAS proto-oncogene, GTPase
|
Enzyme modulator
|
7.9E-04 |
0.320 |
0.923 |
| TGFB1 |
P01137
|
transforming growth factor beta 1
|
Signaling
|
3.7E-02 |
0.287 |
0.962 |
| AFP |
P02771
|
alpha fetoprotein
|
Transporter
|
1.1E-11 |
0.429 |
0.885 |
| ESR1 |
P03372
|
estrogen receptor 1
|
Nuclear receptor
|
1.00 |
0.324 |
0.962 |
| TP53 |
P04637
|
tumor protein p53
|
Transcription factor
|
0.53 |
0.236 |
0.962 |
| GSTP1 |
P09211
|
glutathione S-transferase pi 1
|
|
1.4E-02 |
0.383 |
0.923 |
| AR |
P10275
|
androgen receptor
|
Nuclear receptor
|
0.99 |
0.351 |
0.846 |
| BCL2 |
P10415
|
BCL2 apoptosis regulator
|
Signaling
|
0.56 |
0.291 |
0.885 |
| KIT |
P10721
|
KIT proto-oncogene, receptor tyrosine kinase
|
Kinase
|
0.98 |
0.366 |
0.808 |
| CDH1 |
P12830
|
cadherin 1
|
|
0.15 |
0.401 |
0.808 |
| KITLG |
P21583
|
KIT ligand
|
|
0.85 |
0.473 |
0.885 |
| FGFR3 |
P22607
|
fibroblast growth factor receptor 3
|
Kinase
|
1.6E-05 |
0.391 |
0.846 |
| MRC1 |
P22897
|
mannose receptor C-type 1
|
|
0.94 |
0.413 |
0.846 |
| BRCA1 |
P38398
|
BRCA1 DNA repair associated
|
Enzyme
|
9.2E-29 |
0.367 |
0.923 |
| GDNF |
P39905
|
glial cell derived neurotrophic factor
|
Signaling
|
0.20 |
0.434 |
0.885 |
| FHIT |
P49789
|
fragile histidine triad diadenosine triphosphatase
|
|
5.7E-03 |
0.444 |
0.846 |
| PTEN |
P60484
|
phosphatase and tensin homolog
|
Enzyme
|
0.26 |
0.305 |
0.923 |
| POU5F1 |
Q01860
|
POU class 5 homeobox 1
|
|
0.95 |
0.441 |
0.846 |